Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Fei Cheng

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse]Yan-rong Liu, Yan Chang, Jia-yu Fu, et al.
Bone Marrow Transplantation|April 6, 2023
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantationJun Kong, Feng-Mei Zheng, Zhi-Dong Wang, et al.
Bone Marrow Transplantation|November 14, 2022
The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual diseaseMing Wang, Bixia Wang, Lan-Ping Xu, et al.
Medcomm|June 8, 2026
Dynamic Immune Reconstitution and Clinical Outcomes of Three Different Protocols for Haploidentical Hematopoietic Stem Cell TransplantationXiao-Di Ma, Jie Ji, Zheng-Li Xu, et al.
Haematologica|June 19, 2025
Randomized trial of anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease in haploidentical transplantationZheng-Li Xu, Ting-Ting Han, Xiao-Lu Zhu, et al.
HLA|November 20, 2023
The impact of donor-specific anti-HLA antibody levels on primary poor graft function and graft rejection in rituximab desensitized haploidentical stem cell transplantationJing Liu, Xiang-Yu Zhao, Lan-Ping Xu, et al.
British Journal of Haematology|September 2, 2023
Long-term follow-up of haploidentical haematopoietic stem cell transplantation in paediatric patients with high-risk acute myeloid leukaemia: Report from a single centreLu Bai, Zhi-Xiao Zhang, Guan-Hua Hu, et al.
Leukemia|July 21, 2021
Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantationXiang-Yu Zhao, Zheng-Li Xu, Xiao-Dong Mo, et al.
Leukemia Research|August 25, 2022
Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutationHuan Chen, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|April 13, 2026
Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomesMing-Hao Lin, Sheng-Nan Gao, Xiao-Jun Huang, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse]Yan-rong Liu, Yan Chang, Jia-yu Fu, et al.
Bone Marrow Transplantation|April 6, 2023
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantationJun Kong, Feng-Mei Zheng, Zhi-Dong Wang, et al.
Bone Marrow Transplantation|November 14, 2022
The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual diseaseMing Wang, Bixia Wang, Lan-Ping Xu, et al.
Medcomm|June 8, 2026
Dynamic Immune Reconstitution and Clinical Outcomes of Three Different Protocols for Haploidentical Hematopoietic Stem Cell TransplantationXiao-Di Ma, Jie Ji, Zheng-Li Xu, et al.
Haematologica|June 19, 2025
Randomized trial of anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease in haploidentical transplantationZheng-Li Xu, Ting-Ting Han, Xiao-Lu Zhu, et al.
HLA|November 20, 2023
The impact of donor-specific anti-HLA antibody levels on primary poor graft function and graft rejection in rituximab desensitized haploidentical stem cell transplantationJing Liu, Xiang-Yu Zhao, Lan-Ping Xu, et al.
British Journal of Haematology|September 2, 2023
Long-term follow-up of haploidentical haematopoietic stem cell transplantation in paediatric patients with high-risk acute myeloid leukaemia: Report from a single centreLu Bai, Zhi-Xiao Zhang, Guan-Hua Hu, et al.
Leukemia|July 21, 2021
Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantationXiang-Yu Zhao, Zheng-Li Xu, Xiao-Dong Mo, et al.
Leukemia Research|August 25, 2022
Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutationHuan Chen, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|April 13, 2026
Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomesMing-Hao Lin, Sheng-Nan Gao, Xiao-Jun Huang, et al.
Pageof 9